Skip to content

Impact of Nasal Mask Versus Nasal Cannula Oxygenation on Hypoxemia in Gastrointestinal Endoscopy: A Brain Function Monitoring (SedLine)-Guided Randomized Controlled Trial (NAMSHIC)

Comparison of the Efficacy of Nasal Mask and Nasal Cannula Oxygenation During Gastrointestinal Endoscopic Procedures Performed Under Target-Controlled Propofol Infusion Anesthesia With Brain Function Monitoring (SedLine): A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07500779
Acronym
NAMSHIC
Enrollment
600
Registered
2026-03-30
Start date
2025-01-06
Completion date
2025-11-15
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conscious Sedation, Hypoxemia

Keywords

Gastrointestinal Endoscopy, Propofol, Target-Controlled Infusion, SedLine, Nasal Mask, Nasal Cannula, Oxygenation, Pulse Oximetry

Brief summary

This randomized controlled trial compared the efficacy of a nasal mask versus a standard nasal cannula for oxygen delivery during gastrointestinal endoscopic procedures performed under target controlled propofol infusion anesthesia with SedLine brain function monitoring. Hypoxemia during procedural sedation is a common and clinically relevant event, especially during upper endoscopy and combined procedures. The study aimed to determine whether nasal mask oxygenation reduces hypoxemia compared with nasal cannula oxygenation when sedation depth is guided with electroencephalography based monitoring. Eligible adult patients undergoing gastrointestinal endoscopic procedures were randomly assigned to receive oxygen either via a nasal mask or via a nasal cannula. Oxygen was administered at a fixed flow rate according to the study protocol. Sedation was provided with target controlled propofol infusion, and SedLine monitoring was used to guide sedation depth throughout the procedure. The primary outcome was the occurrence of hypoxemia, defined as peripheral oxygen saturation at or below 90 percent. Secondary outcomes included severe hypoxemia, duration of hypoxemia, lowest peripheral oxygen saturation value, need for airway interventions, other adverse events during the procedure, procedure time, recovery time, and operator satisfaction ratings. The study has been completed.

Detailed description

This study was a prospective randomized controlled trial designed to compare two oxygen delivery approaches during gastrointestinal endoscopic procedures performed under target controlled propofol infusion anesthesia with SedLine brain function monitoring. The main objective was to evaluate whether nasal mask oxygenation provides better protection against hypoxemia than standard nasal cannula oxygenation when sedation depth is actively guided with electroencephalography based monitoring. Adult patients scheduled for gastrointestinal endoscopic procedures were assessed for eligibility and enrolled after appropriate ethical approval and informed consent procedures in accordance with local regulations. Participants were randomly assigned to one of two groups. In the nasal mask group, oxygen was delivered using a nasal mask device. In the nasal cannula group, oxygen was delivered using a standard nasal cannula. Oxygen flow was administered as specified in the protocol. Sedation for all patients was provided with target controlled propofol infusion. SedLine brain function monitoring was used to guide and standardize sedation depth during the procedure to reduce variability related to over sedation or under sedation. The primary outcome was hypoxemia, defined as peripheral oxygen saturation at or below 90 percent. Secondary outcomes included severe hypoxemia, duration of hypoxemia, the minimum peripheral oxygen saturation recorded, need for airway support or rescue interventions, procedure related adverse events such as cough, hiccup, nausea, vomiting, reflux, aspiration, and laryngospasm, total procedure time, recovery time, and satisfaction ratings by the anesthesiologist and the endoscopist. All outcomes were assessed during the procedure and the immediate recovery period based on standardized definitions in the study protocol. The study has been completed, and the collected data are intended to support evaluation of the comparative effectiveness and safety of nasal mask versus nasal cannula oxygenation in this clinical setting.

Interventions

DEVICENasal Mask Oxygenation

Oxygen supplementation delivered via a nasal mask at the protocol specified flow rate during the procedure.

DEVICENasal Cannula Oxygenation

Oxygen supplementation delivered via a standard nasal cannula at the protocol specified flow rate during the procedure.

Sponsors

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Open label due to the visible nature of the oxygen delivery device. Outcome measures were based on objective pulse oximetry and standardized definitions.

Intervention model description

Parallel group randomized controlled trial comparing nasal mask versus nasal cannula oxygenation during gastrointestinal endoscopic procedures performed under target controlled propofol infusion with SedLine monitoring.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years or older. Scheduled for gastrointestinal endoscopic procedures (upper endoscopy and or colonoscopy) under propofol sedation using target controlled infusion with SedLine monitoring. American Society of Anesthesiologists (ASA) physical status I to III. Provided written informed consent.

Exclusion criteria

* Refusal or inability to provide informed consent. Known allergy or contraindication to propofol or study related materials. Severe cardiorespiratory instability or conditions judged by the investigator to increase procedural risk. Pregnancy. Requirement for tracheal intubation or general anesthesia at the outset of the procedure. Significant anatomic or clinical factors precluding use of the assigned oxygen delivery device.

Design outcomes

Primary

MeasureTime frameDescription
HypoxemiaDuring the endoscopic procedure and immediate recovery period (from start of sedation to discharge from the recovery area).Occurrence of hypoxemia defined as peripheral oxygen saturation (SpO2) ≤ 90% during the procedure

Secondary

MeasureTime frameDescription
Severe hypoxemiaDuring the endoscopic procedure and immediate recovery periodSpO2 ≤ 75% at any time, or SpO2 ≤ 90% lasting ≥ 60 seconds.
Duration of hypoxemiaDuring the endoscopic procedure and immediate recovery period.Total duration (seconds) with SpO2 ≤ 90%.
Minimum SpO2During the endoscopic procedureLowest SpO2 recorded during the procedure.
Need for airway interventionsDuring the endoscopic procedure and immediate recovery periodAny airway rescue or supportive intervention required (e.g., airway repositioning, jaw thrust, increased oxygen, mask ventilation, or other emergency airway management).
Procedure-related adverse eventsDuring the endoscopic procedure and immediate recovery period.Cough, hiccup, nausea, vomiting, reflux, aspiration, laryngospasm, and other adverse events.
Procedure timeDuring the procedure.Total procedure duration (minutes).
Recovery timeImmediately after the procedureTime from end of procedure to readiness for discharge from recovery (minutes).
Satisfaction ratingsmmediately after the procedure, during recovery (same day).Anesthesiologist and endoscopist satisfaction assessed using a 0-100 Numeric Rating Scale, where 0 = least satisfied and 100 = most satisfied (higher scores indicate greater satisfaction)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026